Rethink Tomorrow

Welcome to

The Novozymes
Report 2016

Explore

Market leader in
industrial enzymes

Sales by geography

Sales to developed markets constituted around 65% of sales and sales to emerging markets around 35%, on par with 2015. Sales to developed markets grew by 1% organically, and sales to emerging markets grew by 5% organically compared with 2015.

Explore sales performance across regions by clicking on the illustration to the right.

Sales by geography
North America

34%

of sales

-5%

organic sales
growth

North America

Sales declined by 5% organically and in DKK compared with 2015. Sales to Household Care increased, whereas all other areas declined.

Sales by geography
Latin America

10%

of sales

4%

organic sales
growth

Latin America

Sales increased by 4% organically and by 2% in DKK compared with 2015. Agriculture & Feed and Bioenergy contributed to growth, whereas Household Care and Food & Beverages declined.

Sales by geography
Europe, Middle East & Africa

36%

of sales

6%

organic sales
growth

Europe, Middle East & Africa

Sales increased by 6% organically and by 5% in DKK compared with 2015. All areas contributed to growth and the most significant contributors were Technical & Pharma and Agriculture & Feed.

Sales by geography
Asia Pacific

20%

of sales

7%

organic sales
growth

Asia Pacific

Sales grew by 7% organically and by 5% in DKK compared with 2015. All areas contributed to growth, and the most significant areas were Household Care and Food & Beverages.

Globe
Industry

Sales by industry

In 2016, Novozymes’ sales grew by 2% organically and by 1% in DKK, primarily driven by Agriculture & Feed and Technical & Pharma.


Explore sales performance across industries by clicking on the illustration to the left.

Sales by industry

33%

of sales

2 %

organic sales
growth

Household Care

Sales to the Household Care industry increased by 2% organically and in DKK compared with 2015. The division has made good progress on the key strategic initiatives throughout 2016, with continued progress expected in 2017. Market interest in new enzyme technology is very strong.

Sales by industry

26%

of sales

2 %

organic sales
growth

Food & Beverages

Sales to the Food & Beverages industries increased by 2% organically and increased by 1% in DKK compared with 2015.

Sales by industry

17%

of sales

-3 %

organic sales
growth

Bioenergy

Sales to the Bioenergy industry decreased by 3% organically and by 4% in DKK compared with 2015.

Sales by industry

16%

of sales

5 %

organic sales
growth

Agriculture & Feed

Sales to the Agriculture & Feed Industries increased by 5% organically and by 4% in DKK compared with 2015. Sales growth was driven by solid sales growth in Feed and moderate sales growth in BioAg.

Sales by industry

8%

of sales

13 %

organic sales
growth

Technical & Pharma

Sales to the Technical & Pharma industries increased by 13% organically and by 8% in DKK compared with 2015. The strong growth was mainly driven by sales of enzymes for pharmaceutical production, sales of hyaluronic acid and contributions from the royalty agreement with GSK.

Key events

Business model

Explore our business model and see how we innovate, produce and supply our biological solutions to customers in various industries worldwide.

Targets



 

Key performance

Organic sales growth

2%

EBIT margin

27.9%

ROIC

25.1%

Water efficiency improved by

6%

Energy efficiency improved by

10%

CO2 intensity improved by

16%

Renewable energy improved by

24%